Alzheimer's, type 2 diabetes

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.
Alzheimer’s Breakthrough: Popular Diabetes Drug Ozempic Linked to Much Lower Risk
Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. Researchers at Case Western Reserve School of Medicine have found that semaglutide,
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.
Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease
Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).
Could Ozempic lower the risk of Alzheimer’s?
Ozempic has quickly become a household name with medical researchers claiming the breakthrough drug can have many benefits.
Popular Diabetes and Weight-loss Drug May Lower Alzheimer's Risk
‘What’s the issue?’: Perak MB says Chinese tourists waving their national flag not an offence, cops to determine if they were Malaysians or otherwise The most beautiful brides from the movies 20 very angry-looking cars Former star footballer Abdelaziz Barrada dies at 35 years of age 4-day Deepavali weekend for Hindu civil servants Putin wants peace in Ukraine Revisiting the mistake Trump made that put into question his capability to govern Pahang Sultan's son, Tengku Muhammad marries Tengku Natasya
Wegovy Maker Novo Nordisk Says New Pill Shows 14% Reduction in Heart Attacks, Strokes in Diabetic Patients
The Wegovy makers’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in ...
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study
Novo Nordisk said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular ...
The Express Tribune20h
Diabetes drug Semaglutide may reduce kidney damage, study finds
Semaglutide, the diabetes drug also known as Ozempic, has shown positive effects in treating patients with chronic kidney ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News
Eli Lilly expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News ...
UPI10d
Study: Men using diabetes drug metformin won't increase birth defect risk
A new, reassuring study finds that men can take the diabetes drug metformin without worrying that their offspring will ...
Ars Live: What else can GLP-1 drugs do? Join us Tuesday for a discussion.
News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...